Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA advisory committee will meet to discuss Ergoset NDA

April 14, 1998

OSI Pharmaceuticals and Hoechst Marion Roussel extend EPO collaboration

April 14, 1998

Overview of preclinical and clinical data for rHuMGDF

April 14, 1998

YM-175: a new-generation bisphosphonate with antihypercalcemic activity

April 14, 1998

Novel GH secretagogues disclosed by Novo Nordisk

April 9, 1998

NPY Y1 receptor ligands for eating and cardiovascular disorders

April 9, 1998

HBOC-201 reduces need for blood transfusions in surgery

April 8, 1998

Advisory committee meeting scheduled for atosiban NDA review

April 8, 1998

Discovery Laboratories begins phase Ib trials of ST-630

April 8, 1998

Phase Ib results reported for allosteric Hb modifier RSR13

April 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...